Works by Kaiser, Martin

Results: 177
    1

    Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.

    Published in:
    2021
    By:
    • Jackson, Graham H.;
    • Pawlyn, Charlotte;
    • Cairns, David A.;
    • de Tute, Ruth M.;
    • Hockaday, Anna;
    • Collett, Corinne;
    • Jones, John R.;
    • Kishore, Bhuvan;
    • Garg, Mamta;
    • Williams, Cathy D.;
    • Karunanithi, Kamaraj;
    • Lindsay, Jindriska;
    • Rocci, Alberto;
    • Snowden, John A.;
    • Jenner, Matthew W.;
    • Cook, Gordon;
    • Russell, Nigel H.;
    • Drayson, Mark T.;
    • Gregory, Walter M.;
    • Kaiser, Martin F.
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk.

    Published in:
    2021
    By:
    • Duran-Lozano, Laura;
    • Thorleifsson, Gudmar;
    • Lopez de Lapuente Portilla, Aitzkoa;
    • Niroula, Abhishek;
    • Went, Molly;
    • Thodberg, Malte;
    • Pertesi, Maroulio;
    • Ajore, Ram;
    • Cafaro, Caterina;
    • Olason, Pall I.;
    • Stefansdottir, Lilja;
    • Bragi Walters, G.;
    • Halldorsson, Gisli H.;
    • Turesson, Ingemar;
    • Kaiser, Martin F.;
    • Weinhold, Niels;
    • Abildgaard, Niels;
    • Andersen, Niels Frost;
    • Mellqvist, Ulf-Henrik;
    • Waage, Anders
    Publication type:
    Correction Notice
    14

    Germline variants at SOHLH2 influence multiple myeloma risk.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 4, p. 1, doi. 10.1038/s41408-021-00468-6
    By:
    • Duran-Lozano, Laura;
    • Thorleifsson, Gudmar;
    • Lopez de Lapuente Portilla, Aitzkoa;
    • Niroula, Abhishek;
    • Went, Molly;
    • Thodberg, Malte;
    • Pertesi, Maroulio;
    • Ajore, Ram;
    • Cafaro, Caterina;
    • Olason, Pall I.;
    • Stefansdottir, Lilja;
    • Bragi Walters, G.;
    • Halldorsson, Gisli H.;
    • Turesson, Ingemar;
    • Kaiser, Martin F.;
    • Weinhold, Niels;
    • Abildgaard, Niels;
    • Andersen, Niels Frost;
    • Mellqvist, Ulf-Henrik;
    • Waage, Anders
    Publication type:
    Article
    15

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    16
    17
    18

    Sanfte Festkörperchemie.

    Published in:
    Nachrichten aus der Chemie, 2013, v. 61, n. 1, p. 26, doi. 10.1002/nadc.201390006
    By:
    • Groh, Matthias F.;
    • Heise, Martin;
    • Kaiser, Martin;
    • Ruck, Michael
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    MILWAUKEE JOURNAL SENTINEL.

    Published in:
    Newspaper Research Journal, 2003, v. 24, n. 1, p. 107, doi. 10.1177/073953290302400112
    By:
    • Kaiser, Martin
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    OAB-060: Prospective comparison of contemporary whole body MRI and FDG PET/CT for disease detection and correlation with markers of disease burden in myeloma: results of the iTIMM trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S37, doi. 10.1016/S2152-2650(21)02132-7
    By:
    • Kaiser, Martin;
    • Porta, Nuria;
    • sharma, Bhupinder;
    • Levine, Daniel;
    • Dow-Mu Koh;
    • Boyd, Kevin;
    • Pawlyn, Charlotte;
    • Ridell, Angela;
    • Downey, Katherine;
    • Croft, James;
    • Bonner, Alison;
    • Morgan, Veronica;
    • Stern, Simon;
    • Jones, Lydia;
    • Cheung, Betty;
    • Kyriakou, Charalampia;
    • Kaczmarek, Pawel;
    • Winfield, jessica;
    • Blackledge, Matthew;
    • Oyen, Wim
    Publication type:
    Article
    43

    OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S10, doi. 10.1016/S2152-2650(21)02089-9
    By:
    • De Tute, Ruth;
    • Pawlyn, Charlotte;
    • Cairns, David;
    • Davies, Faith;
    • Rawstron, Andy;
    • Jones, John;
    • Hockaday, Anna;
    • Menzies, Tom;
    • Henderson, Rowena;
    • Cook, Gordon;
    • Drayson, Mark;
    • Jenner, Matthew;
    • Kaiser, Martin;
    • Gregory, Walter;
    • Morgan, Gareth;
    • Jackson, Graham;
    • Owen, Roger
    Publication type:
    Article
    44

    OAB-012: Depth of response and MRD in newly diagnosed ultra high-risk myeloma and plasma cell leukemia treated with Dara-CVRd and V-MEL ASCT: results of the molecularly stratified UK OPTIMUM/MUKnine trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S8, doi. 10.1016/S2152-2650(21)02086-3
    By:
    • Kaiser, Martin;
    • Hall, Andrew;
    • Walker, Katrina;
    • Tute, Ruth De;
    • Roberts, Sadie;
    • Ingleson, Emma;
    • Bowles, Kristian;
    • Garg, Mamta;
    • Lokare, Anand;
    • Messiou, Christina;
    • Jackson, Graham;
    • Pratt, Guy;
    • Cook, Gordon;
    • Drayson, Mark;
    • Owen, Roger;
    • Brown, Sarah;
    • Jenner, Matthew
    Publication type:
    Article
    45
    46
    47
    48
    49

    Management of adverse events (AEs) observed in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma (MM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e293, doi. 10.1016/j.clml.2019.09.481
    By:
    • Kaiser, Martin;
    • Beksac, Meral;
    • Gulbrandsen, Nina;
    • Schjesvold, Fredrik;
    • Hajek, Roman;
    • Moreau, Philippe;
    • de Arriba, Felipe;
    • Mateos, Maria-Victoria;
    • West, Sharon;
    • Spencer, Andrew;
    • Rajkumar, S.Vincent;
    • Suryanarayan, Kaveri;
    • Czorniak, Michael;
    • Teng, Zhaoyang;
    • Labotka, Richard;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    50